While I believe Pfizer will rebound eventually, it will take some time to do so, and it may not occur in 2026. In the ...

KalVista reports early EKTERLY sales momentum, rising prescriber adoption and global regulatory approvals following the drug's 2025 launch.

According to MarketsandMarkets, the report "Flexible Plastic Bags Packaging Market by Application (Food, Beverages, Pharmaceutical & healthcare) ...

What was once a possibility of rain on Christmas has now become a certainty as a powerful storm barrels toward Southern California – with alarming rainfall totals anticipated. The National Weather ...

Nine pharmaceutical companies including Bristol-Myers Squibb, GSK and Merck agreed to lower the prices that certain federal government programs and patients pay, in a new round of industry pacts with ...

AI market forecasting is reshaping how organizations anticipate demand, risk, and opportunity by processing massive volumes of structured and unstructured data in near real time. Modern systems ingest ...

Pharma marketers enter 2026 asking where DTC fits in the DTP era. That question, which few foresaw 12 months ago, reflects the fast rise of direct-to-patient (DTP) programs. In the last few months ...

Amid rapidly evolving media consumption habits and a federal push to limit direct-to-consumer drug advertising, pharma companies in 2026 and beyond are on track to continue their migration away from ...

LOWERING DRUG PRICES FOR AMERICAN PATIENTS: Today, President Donald J. Trump announced nine new agreements with major pharmaceutical companies to lower prescription drug prices for Americans in line ...